Bio-Techne Corp at Robert W Baird Global Healthcare Conference Transcript
Everybody, I'm Catherine Schulte. I cover Life Sciences and Diagnostics here at Baird. We're very pleased to have Bio-Techne presenting here today representing the company. So if you have a question at any time, you can email [email protected]. And I will pass it along to Chuck. Chuck?
Great. All right, I'm on this, good. First slide, there's our new tagline, so Where Science Intersects Innovation. If you guys have ever worked on a tagline, it's harder than it sounds. I'd say dozens of hours of conflict within the team, but I like this one, finally. I think marketing finally nailed it. So -- and we're a lot about science, and we think we're a lot about innovation. And we've certainly been growing and there's a lot to talk about, so. Next slide. Guess I could do it. So we're -- we were up as high as $8 billion, it's been a tough market the last few weeks. But we're up to
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |